About AMRIX
Consistent Plasma Levels
Multiple-Day Pharmacokinetics of Once-Daily AMRIX
Cyclobenzaprine exposure with AMRIX is less than with cyclobenzaprine IR at steady-state concentrations.12

- At steady-state concentrations, exposure to cyclobenzaprine is 30% less with AMRIX than with cyclobenzaprine IR*
- With AMRIX, 90% of the steady-state plasma concentration is achieved by Day 4
AMRIX may enhance the effects of alcohol, barbiturates, and other CNS depressants. AMRIX should not be used in elderly patients or in patients with impaired hepatic function.
*The Day 7 Cavg was predicted using single-dose data from pharmacokinetic study 1107 and 7-day data from pharmacokinetic study 1104.